Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 0 | 0 | 0 | 0 | 45 |
| Gross Profit | N/A | N/A | N/A | 0 | 45 |
| Operating Expenses | 14,351 | 15,642 | 11,584 | 11,291 | 9,844 |
| Operating Income | -14,351 | -15,642 | -11,584 | -11,291 | -9,799 |
| Other Income | 1,075 | 461 | 547 | 644 | 325 |
| Pre-tax Income | -13,276 | -15,181 | -11,037 | -10,647 | -9,474 |
| Net Income Continuous | -13,276 | -15,181 | -11,037 | -10,647 | -9,474 |
| Net Income | $-13,276 | $-15,181 | $-11,037 | $-10,647 | $-9,474 |
| EPS Basic Total Ops | -0.49 | -0.58 | -0.43 | -0.43 | -0.38 |
| EPS Basic Continuous Ops | -0.49 | -0.58 | -0.43 | -0.43 | -0.38 |
| EPS Diluted Total Ops | -0.49 | -0.58 | -0.43 | -0.43 | -0.38 |
| EPS Diluted Continuous Ops | -0.49 | -0.58 | -0.43 | -0.43 | -0.38 |
| EBITDA(a) | $-14,151 | $-15,433 | $-11,402 | $-11,130 | $-9,578 |